Mesoamerican Nephropathy (MeN): What We Know so Far

被引:23
|
作者
Sanchez Polo, Vicente [1 ]
Garcia-Trabanino, Ramon [2 ,3 ]
Rodriguez, Guillermo [4 ]
Madero, Magdalena [5 ]
机构
[1] Inst Guatemalteco Seguridad Social, Guatemala City, Guatemala
[2] Ctr Hemodialisis, San Salvador, El Salvador
[3] Fondo Social Emergencia Salud, Tierra Blanca, El Salvador
[4] Hosp Dr RA Calderon Guardia, Serv Nephrol, Caja Costarricense Seguro Social, San Jose, Costa Rica
[5] Inst Nacl Cardiol Ignacio Chavez, Div Nephrol, Juan Badiano 1,Col Secc 16, Mexico City 14080, DF, Mexico
关键词
Mesoamerican nephropathy; MeN; heat stress; CKDu; CKDnt; endemic nephropathy; regional nephropathy; CHRONIC KIDNEY-DISEASE; AGRICULTURAL COMMUNITIES; INTERNATIONAL SOCIETY; UNKNOWN ETIOLOGY; CENTRAL-AMERICA; HEAT-STRESS; DEHYDRATION; RISK; DISPARITIES; MORTALITY;
D O I
10.2147/IJNRD.S270709
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
In 2002, a report from El Salvador described a high incidence of chronic kidney disease (CKD) of unknown cause, mostly in young males from specific coastal areas. Similar situations were observed along the Pacific Ocean coastline of other Central American countries and southern Mexico (Mesoamerica). This new form of CKD has been denominated Mesoamerican endemic nephropathy (MeN). The typical presentation of MeN is a young male from an endemic area with a family history of CKD, low eGFR, high serum creatinine, low level of albuminuria, hypokalemia, hyperuricemia, and urine urate crystals. Kidney biopsy demonstrating tubulointerstitial nephritis remains the gold standard for diagnosis but is available only for a minority. Commonly proposed causes include thermal stress/dehydration and/or exposure to environmental pollutants. However, likely, a third factor, which could be genetic or epigenetic, could contribute to the cause and development of the disease, along with social determinants. Currently, preventive measures focus on minimizing workers exposure to thermal stress/dehydration. There are many research opportunities and priorities should include clinical trials to evaluate the efficacy and safety of the current treatment protocols, along with etiological and genetic studies, and the development of kidney disease data systems. Although there is scant and controversial literature with regard s to the etiology, diagnosis and management of the disease, our aim is to provide the reader a vision of the disease based on our experience.
引用
收藏
页码:261 / 272
页数:12
相关论文
共 50 条
  • [1] What we know so far
    不详
    NEW SCIENTIST, 2021, 245 (3347) : 8 - 8
  • [2] What we know so far
    Gazzard, B
    AIDS, 1996, 10 : S3 - S7
  • [3] Vomocytosis: What we know so far
    Seoane, Paula I.
    May, Robin C.
    CELLULAR MICROBIOLOGY, 2020, 22 (02)
  • [4] Anabaenopeptins: What We Know So Far
    Monteiro, Patrick Romano
    do Amaral, Samuel Cavalcante
    Siqueira, Andrei Santos
    Xavier, Luciana Pereira
    Santos, Agenor Valadares
    TOXINS, 2021, 13 (08)
  • [5] Amyloidogenesis: What Do We Know So Far?
    Alraawi, Zeina
    Banerjee, Nayan
    Mohanty, Srujana
    Kumar, Thallapuranam Krishnaswamy Suresh
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)
  • [6] ASPHALTENES: WHAT DO WE KNOW SO FAR
    Al-Qasim, Abdulaziz S.
    Alasker, Mohammed
    PROCEEDINGS OF THE ASME 36TH INTERNATIONAL CONFERENCE ON OCEAN, OFFSHORE AND ARCTIC ENGINEERING, 2017, VOL 8, 2017,
  • [7] Melanoma vaccines: What we know so far
    Bystryn, Jean-Claude
    Reynolds, Sandra R.
    ONCOLOGY-NEW YORK, 2005, 19 (01): : 97 - 108
  • [8] Incremental Hemodialysis: What We Know so Far
    Soi, Vivek
    Faber, Mark D.
    Paul, Ritika
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2022, 15 : 161 - 172
  • [9] Trichotillomania: What Do We Know So Far?
    Melo, Daniel Fernandes
    Lima, Caren dos Santos
    Piraccini, Bianca Maria
    Tosti, Antonella
    SKIN APPENDAGE DISORDERS, 2022, 8 (01) : 1 - 7
  • [10] Probiotics: What Do We Know So Far?
    Steinberg, Skylar
    Hazan, Sabine
    PRACTICAL GASTROENTEROLOGY, 2018, 42 (10) : 68 - 70